Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.38.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.38.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.38.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-22590.4China
BF.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BM.1.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.1.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2266.25Germany
BM.1.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.1.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-6061.14China
BM.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BF.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used